(Q46420401)

English

The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion model (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

author name string

Brook NR

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

Waller JR

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

Bicknell GR

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

Nicholson ML

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

language of work or name

0 references

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

37

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

130-133

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.150

7 January 2021

Reproducibility in the quantification of mRNA levels by RT-PCR-ELISA and RT competitive-PCR-ELISA

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.150

7 January 2021

Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.150

7 January 2021

Pirfenidone inhibits early myointimal proliferation but has no effect on late lesion size in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.150

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2004.12.150

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

release_o4am4iihdjgsfpu7zbq4ldsgfi

1 reference

https://api.fatcat.wiki/v0/release/o4am4iihdjgsfpu7zbq4ldsgfi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808571

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46420401&oldid=2110499415"